Diflunisal

Attrogy 250 MG Comprimidos Recubiertos con Pelicula

250 mg comprimido recubierto con películaSpainMarketedAuthorised 10 Dec 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AttrogyEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Diflunisal

Attrogy 250 MG Comprimidos Recubiertos con Pelicula

250 mg comprimido recubierto con películaSpainMarketedAuthorised 10 Dec 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AttrogyEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Diflunisal-250 - Tab 250MGCanada · 250 MG / TAB · Tablet · Pro Doc Limitee

DiflunisalUnited States · 250MG, 375MG, 500MG · tablet · Dastech Intl

DolobidUnited States · 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Merck

DolobidSaudi Arabia · Merck Sharp & Dohme

Packs

Pack	Code	Status
ATTROGY 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos	769467

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Diflunisal
Strength: 250 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 10 Dec 2025
Registration: 1251929001
Marketing authorisation holder: Purpose Pharma International Ab
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/25/1929